Business | NDTV Correspondent | Saturday November 26, 2011
Drug major Ranbaxy today said it has entered into an agreement with US-headquartered Gilead Sciences to manufacture and market three new generic HIV/AIDS drugs in India and developing countries.
The company has entered into an 'in-licencing agreement' with Gilead Sciences Inc to produce and sell, under licence, three new HIV/AIDS...
www.ndtv.com/business